B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Ulixertinib

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Ulixertinib, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

olomoucine
2 shared targets
nalfurafine
2 shared targets
aloisine
2 shared targets
trametinib
2 shared targets · score 45.1
iodoquinol
2 shared targets
ravoxertinib
3 shared targets
tanzisertib
2 shared targets
hymenialdisine
2 shared targets
zafirlukast
2 shared targets
withaferin
2 shared targets · score 42.6
Loading evidence profile...

This evidence profile for Ulixertinib is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.